Login / Signup

Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.

Patrick SchindlerOrhan AktasMarius RingelsteinBrigitte WildemannSven JariusFriedemann PaulKlemens Ruprecht
Published in: Expert review of clinical immunology (2022)
NMOSD and could have the potential for application in clinical practice.
Keyphrases
  • spectrum disorder
  • clinical practice
  • neuropathic pain
  • protein protein
  • ionic liquid
  • binding protein
  • human health
  • spinal cord injury
  • climate change